Neither rofecoxib nor naproxen slows cognitive decline in people with mild-to-moderate Alzheimer's disease

P. S. Aisen, K. A. Schafer, M. Grundman, David Knopman, Naji Tabet

Research output: Contribution to journal › Short survey › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Neither rofecoxib nor naproxen slows cognitive decline in people with mild-to-moderate Alzheimer's disease'. Together they form a unique fingerprint.